Theorem Clinical Research

Global News

MTTI, National Health Research Institutes collaborate for cancer

Thursday, August 7, 2014 12:00 PM

Molecular Targeting Technologies (MTTI), a privately held biotechnology company, and National Health Research Institutes (NHRI), Taiwan, have collaborated to develop novel cancer therapeutics using the proprietary DPA delivery technology to carry anticancer drugs that can be specifically delivered to and released at the tumor sites.

More... »


Report: Global market for DNA vaccines to reach $2.7B in 2019

Thursday, August 7, 2014 11:00 AM

According to a new BCC Research report, the global market for DNA vaccines is expected to grow to $2.7 billion by 2019, with a five-year compound annual growth rate (CAGR) of 54.8%. The clinical vaccines category, the largest and fastest-growing segment of this market, is surging at 81.2% CAGR.

More... »


Ventana, Quintiles ink agreement for companion diagnostic services in China

Thursday, August 7, 2014 10:00 AM

Ventana Medical Systems, a member of the Roche Group, has inked a new agreement with Quintiles to offer College of American Pathology (CAP) standard companion diagnostic testing services in China for pharmaceutical and biotech companies conducting early phase clinical trials. China is one of the only countries in the world that requires all patient samples be tested in China, even those used in clinical trials.

More... »

Alvogen acquires Korean Dream Pharma for $187 million

Thursday, August 7, 2014 08:00 AM

Alvogen, an international, privately owned pharmaceuticals company, has acquired Dream Pharma of South Korea for $187 million in cash. Dream will be acquired through Alvogen’s Asian subsidiaries and, on completion, the combination will create one of the largest generic pharmaceutical companies in South Korea.

More... »

TractManager acquires MD Buyline, looking to jointly expand hospital services to other healthcare facilities

Wednesday, August 6, 2014 02:56 PM

TractManager, a provider of technology-enabled compliance and contract management services for healthcare organizations, has acquired MD Buyline, a specialist provider of healthcare analytics and supply chain intelligence capabilities for healthcare providers, primarily hospitals.

More... »

Regulus Therapeutics, Biogen Idec collaborate for multiple sclerosis biomarkers

Wednesday, August 6, 2014 12:58 PM

Regulus Therapeutics, a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, has entered into a new collaboration agreement with Biogen Idec to expand its research focused on identifying microRNAs as biomarkers for multiple sclerosis (MS) under its Regulus microMarkers division. The new research will focus on profiling a large number of whole blood samples from a cohort of MS patients who have been treated with a Biogen Idec MS therapy to identify potential microRNA signatures. 

More... »

PatientsLikeMe, Actelion to develop new patient-reported measure for MF-CTCL

Wednesday, August 6, 2014 12:57 PM

PatientsLikeMe and Actelion are partnering in a research initiative to create a new patient-reported outcomes tool for the rare form of non-Hodgkin's lymphoma called MF-CTCL. The collaboration will leverage PatientsLikeMe’s Open Research Exchange (ORE), an online hub for developing and sharing new health measures that better reflect patients’ experiences living with and managing disease.

More... »

DAC Patient Recruitment, Remedy Health Media partner for clinical trial enrollment

Wednesday, August 6, 2014 12:44 PM

DAC Patient Recruitment Services, an Imperial company focusing on clinical trial patient recruitment and retention, has partnered with Remedy Health Media, a health information and technology company, to offer clients exclusive access to millions of potential trial participants in one of the highest-concentration online environments of chronic condition patients and caregivers.

More... »

CluePoints: Determining best approach is industry's biggest challenge to implementing risk-based monitoring

Wednesday, August 6, 2014 08:40 AM

A survey by CluePoints, a provider of centralized statistical monitoring (CSM) solutions for clinical trials, has revealed 42% of respondents across the industry say agreeing to the best and most practical approach is the biggest challenge their organizations face in implementing an effective Risk-Based Monitoring (RBM) strategy.

More... »

ACRES, Fujitsu form strategic alliance around technology

Wednesday, August 6, 2014 08:37 AM

The Alliance for Clinical Research Excellence and Safety (ACRES) has formed a strategic alliance with Fujitsu, a global information and communication technology company, to address challenges facing the development of medicines and health-related research endeavors.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 15

WIRB-Copernicus Group acquires New England IRB

BBK Worldwide secures $3 million in private ἀnancingto accelerate its global and technological expansion

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs